Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.
D000818:Animals; D001053:Apolipoproteins / Q000378:metabolism*; D001120:Arginine / Q000378:metabolism; D001665:Binding Sites; D003512:Cyclohexanones / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D005347:Fibroblasts; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D007223:Infant; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008239:Lysine / Q000378:metabolism; D008297:Male
D001053:Apolipoproteins; D003512:Cyclohexanones; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D006493:Heparin; D001120:Arginine; D008239:Lysine